Skip to main content

Advertisement

Table 2 Differential mRNA expression changes in healthy ASM cells after treatment with FCS or Dex + FCS

From: Role of non-coding RNAs in maintaining primary airway smooth muscle cells

mRNA FCS Dex + FCS
Microarray (FC) qRT-PCR (FC) Microarray (FC) qRT-PCR (FC)
FAM71F1 −1.7 (<.05) −1.62 (<.05) 1.7 (<.05) 1.56 (<.05)
METTL7A −1.9 (<.01) −0.85 (<.05) 2.1 (<.01) 5.77 (<.01)
PLSCR4 −1.5 (<.001) −0.33 (<.05) 1.6 (<.001) 6.47 (<.001)
TUBB3 1.5 (<.05) 1.22 (<.05) −1.7 (<.001) −2.18 (<.05)
WDFY4 −1.8 (<.05) −3.60 (<.01) 1.8 (<.05) 2.01 (<.05)
  1. This table lists those mRNAs that were differentially expressed in healthy ASM cells following stimulation with FCS (2.5%) or treatment with dexamethasone (10−7 M) before stimulation with FCS (2.5%). Microarray data are denoted as the fold change against baseline control and is the mean of 9 individual patients. These values are derived from Additional file 1: Table S1, S2, S3, S4 and are for those genes that demonstrated an FDR of less than 0.05; associated P values are shown in parentheses. FC, Fold change.